A machine learning approach to knee osteoarthritis phenotyping: data from the FNIH Biomarkers Consortium.


Journal

Osteoarthritis and cartilage
ISSN: 1522-9653
Titre abrégé: Osteoarthritis Cartilage
Pays: England
ID NLM: 9305697

Informations de publication

Date de publication:
07 2019
Historique:
received: 24 07 2018
revised: 17 12 2018
accepted: 28 12 2018
pubmed: 20 4 2019
medline: 25 8 2020
entrez: 20 4 2019
Statut: ppublish

Résumé

Knee osteoarthritis (KOA) is a heterogeneous condition representing a variety of potentially distinct phenotypes. The purpose of this study was to apply innovative machine learning approaches to KOA phenotyping in order to define progression phenotypes that are potentially more responsive to interventions. We used publicly available data from the Foundation for the National Institutes of Health (FNIH) osteoarthritis (OA) Biomarkers Consortium, where radiographic (medial joint space narrowing of ≥0.7 mm), and pain progression (increase of ≥9 Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC] points) were defined at 48 months, as four mutually exclusive outcome groups (none, both, pain only, radiographic only), along with an extensive set of covariates. We applied distance weighted discrimination (DWD), direction-projection-permutation (DiProPerm) testing, and clustering methods to focus on the contrast (z-scores) between those progressing by both criteria ("progressors") and those progressing by neither ("non-progressors"). Using all observations (597 individuals, 59% women, mean age 62 years and BMI 31 kg/m Using methods that provide a way to assess numerous variables of different types and scalings simultaneously in relation to an outcome of interest enabled a data-driven approach that identified key variables associated with a progression phenotype.

Identifiants

pubmed: 31002938
pii: S1063-4584(19)30926-4
doi: 10.1016/j.joca.2018.12.027
pmc: PMC6579689
mid: NIHMS1527144
pii:
doi:

Substances chimiques

Biomarkers 0
Collagen Type II 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

994-1001

Subventions

Organisme : NIAMS NIH HHS
ID : P60 AR064166
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Références

Arthritis Rheum. 2009 Mar;60(3):831-9
pubmed: 19248082
PLoS One. 2017 Dec 29;12(12):e0190251
pubmed: 29287118
Osteoarthritis Cartilage. 2016 Apr;24(4):640-6
pubmed: 26620089
BMC Musculoskelet Disord. 2016 Nov 10;17(1):466
pubmed: 27832771
BMC Musculoskelet Disord. 2018 Jan 19;19(1):22
pubmed: 29351749
Osteoarthritis Cartilage. 2015 Dec;23(12):2191-2198
pubmed: 26162806
Ann Rheum Dis. 2009 Sep;68(9):1461-5
pubmed: 18829615
Maturitas. 2015 Sep;82(1):36-49
pubmed: 25963100
Arthritis Rheumatol. 2015 May;67(8):2085-96
pubmed: 25940308
Osteoarthritis Cartilage. 2016 Mar;24(3):458-64
pubmed: 26432512
IEEE Trans Pattern Anal Mach Intell. 1979 Feb;1(2):224-7
pubmed: 21868852
Osteoarthritis Cartilage. 2017 Dec;25(12):1926-1941
pubmed: 28847624
J Rheumatol. 2010 Jun;37(6):1252-9
pubmed: 20395641
J Am Stat Assoc. 2010 Mar 1;105(489):401-414
pubmed: 21152360
Ann Rheum Dis. 2016 Sep;75(9):1607-14
pubmed: 26483253
PLoS One. 2018 Jan 12;13(1):e0191045
pubmed: 29329325
Rheumatology (Oxford). 2018 May 1;57(suppl_4):iv34-iv42
pubmed: 29267932
Biomarkers. 2015;20(8):557-64
pubmed: 26848781
Arthritis Rheumatol. 2015 Dec;67(12):3184-9
pubmed: 26316262
Arthritis Rheum. 2008 Jun;58(6):1716-26
pubmed: 18512777
Rheumatology (Oxford). 2010 Dec;49(12):2413-9
pubmed: 20823092
BMC Musculoskelet Disord. 2016 Oct 12;17(1):425
pubmed: 27733199
Ann Rheum Dis. 2017 Jan;76(1):186-195
pubmed: 27296323
Intern Med J. 2012 Mar;42(3):274-80
pubmed: 21299779
Best Pract Res Clin Rheumatol. 2014 Feb;28(1):61-71
pubmed: 24792945
Rheumatology (Oxford). 2005 Jan;44(1):100-4
pubmed: 15381791
Semin Arthritis Rheum. 2013 Oct;43(2):187-94
pubmed: 24157092
Arthritis Rheumatol. 2016 Oct;68(10):2422-31
pubmed: 27111771

Auteurs

A E Nelson (AE)

Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: aenelson@med.unc.edu.

F Fang (F)

Department of Statistics and Operations Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: fangf@live.unc.edu.

L Arbeeva (L)

Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: liubov_arbeeva@med.unc.edu.

R J Cleveland (RJ)

Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: Rebecca_cleveland@med.unc.edu.

T A Schwartz (TA)

Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: tschwart@email.unc.edu.

L F Callahan (LF)

Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: leigh_callahan@med.unc.edu.

J S Marron (JS)

Department of Statistics and Operations Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: marron@unc.edu.

R F Loeser (RF)

Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: Richard_loeser@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH